Noveome Biotherapeutics Revenue and Competitors

Location

$22.6M

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Noveome Biotherapeutics's estimated annual revenue is currently $2.2M per year.(i)
  • Noveome Biotherapeutics's estimated revenue per employee is $77,500
  • Noveome Biotherapeutics's total funding is $22.6M.

Employee Data

  • Noveome Biotherapeutics has 28 Employees.(i)
  • Noveome Biotherapeutics grew their employee count by 8% last year.

Noveome Biotherapeutics's People

NameTitleEmail/Phone
1
Founder, Chairman & CEOReveal Email/Phone
2
CEOReveal Email/Phone
3
ControllerReveal Email/Phone
4
EVP Mfg and Process SciencesReveal Email/Phone
5
VP Administration & ControllerReveal Email/Phone
6
Associate Director Quality ControlReveal Email/Phone
7
Sr. Regulatory Affairs DirectorReveal Email/Phone
8
EVP and Chief Scientific OfficerReveal Email/Phone
9
Director Research and DevelopmentReveal Email/Phone
10
Director Advanced Analytical SciencesReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$1.6M100%N/AN/A
#2
$4M2613%N/AN/A
#3
$0.9M6-14%N/AN/A
#4
$1.1M70%N/AN/A
#5
$10.9M703%N/AN/A
#6
$0.7M929%N/AN/A
#7
$4M26-16%N/AN/A
#8
$1.7M1122%N/AN/A
#9
$7.6M492%N/AN/A
#10
$1.6M100%N/AN/A
Add Company

What Is Noveome Biotherapeutics?

Noveome Biotherapeutics, Inc. is a clinical stage company focused on breakthrough therapies for the regenerative repair of inflamed or damaged tissues. The company, originally founded as Stemnion, Inc., is located in the heart of Pittsburgh near the Southside Works. Noveome is passionate about growing its business in Allegheny County and helping the region to become a world leader in biotherapeutic research and development. Noveome Biotherapeutics, Inc. is a dynamic biopharmaceutical company with an innovative platform technology that represents a paradigm shift in drug development. Unlike most drugs that are single molecules directed at specific indications, Noveome?s product is a complex mixture of biomolecules that is believed to have the ability to treat a wide range of conditions and injuries. Noveome collaborates with major research centers to advance these therapeutic applications.

keywords:N/A

$22.6M

Total Funding

28

Number of Employees

$2.2M

Revenue (est)

8%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Noveome Biotherapeutics News

2022-04-17 - periodontal disease treatment Market Growth Factors ...

... S.A, Izun Pharmaceuticals Corporation, Dong-A Socio Holdings, Noveome Biotherapeutics, Inc, Kaken Pharmaceutical Co.,Ltd and others.

2019-04-09 - Noveome Biotherapeutics Completes $15M Series D Financing

Noveome Biotherapeutics, Inc., a Pittsburgh, PA-based clinical-stage biopharmaceutical company focused on developing next-generation biologics for the promotion and restoration of cellular integrity of inflamed or damaged tissues, closed a $15m Series D financing. The round was led by a new ins ...

2019-04-09 - Noveome Biotherapeutics Completes $15 Million Series D

PITTSBURGH--(BUSINESS WIRE)--Noveome Biotherapeutics, Inc., a clinical-stage biopharmaceutical company focused on developing next-generation biologics for the promotion and restoration of cellular integrity of inflamed or damaged tissues, today announced the closing of a $15 million Series D fin ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$6.3M28-12%N/A
#2
$15M28-20%N/A
#3
$2.8M28-3%N/A
#4
$4.8M2817%N/A
#5
$3.2M28-3%N/A